AU2001233537A1 - A method of assessing the biological status of pathology in epithelial tissue, especially colon - Google Patents

A method of assessing the biological status of pathology in epithelial tissue, especially colon

Info

Publication number
AU2001233537A1
AU2001233537A1 AU2001233537A AU3353701A AU2001233537A1 AU 2001233537 A1 AU2001233537 A1 AU 2001233537A1 AU 2001233537 A AU2001233537 A AU 2001233537A AU 3353701 A AU3353701 A AU 3353701A AU 2001233537 A1 AU2001233537 A1 AU 2001233537A1
Authority
AU
Australia
Prior art keywords
pathology
assessing
epithelial tissue
biological status
especially colon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001233537A
Inventor
Gabriel G. Altmann
Gregory R. Wade
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procyon Biopharma Inc
Original Assignee
Procyon Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procyon Biopharma Inc filed Critical Procyon Biopharma Inc
Publication of AU2001233537A1 publication Critical patent/AU2001233537A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57419Specifically defined cancers of colon
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04Phospholipids, i.e. phosphoglycerides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001233537A 2000-02-17 2001-02-12 A method of assessing the biological status of pathology in epithelial tissue, especially colon Abandoned AU2001233537A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2299210 2000-02-17
CA002299210A CA2299210A1 (en) 2000-02-17 2000-02-17 A method of assessing the biological status of cancer development
PCT/CA2001/000167 WO2001061358A1 (en) 2000-02-17 2001-02-12 A method of assessing the biological status of pathology in epithelial tissue, especially colon

Publications (1)

Publication Number Publication Date
AU2001233537A1 true AU2001233537A1 (en) 2001-08-27

Family

ID=4165371

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001233537A Abandoned AU2001233537A1 (en) 2000-02-17 2001-02-12 A method of assessing the biological status of pathology in epithelial tissue, especially colon

Country Status (4)

Country Link
US (1) US20020022240A1 (en)
AU (1) AU2001233537A1 (en)
CA (1) CA2299210A1 (en)
WO (1) WO2001061358A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9086403B2 (en) * 2004-06-03 2015-07-21 The Johns Hopkins University Methods of screening for cell proliferation or neoplastic disorders
US7738683B2 (en) * 2005-07-22 2010-06-15 Carestream Health, Inc. Abnormality detection in medical images
AU2008238553B2 (en) 2007-04-13 2014-06-19 Med-Life Discoveries Lp Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging
EP2163239A1 (en) * 2008-05-27 2010-03-17 Qiagen GmbH Products containing bioparticles, method for their manufacture
US20100081928A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological Facilitation systems and methods
US20100081927A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
US20100081915A1 (en) * 2008-09-29 2010-04-01 Searete Llc, Alimited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
US20100081924A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
US20100081926A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
US20100081916A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware. Histological facilitation systems and methods
US20100081190A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
US20100081919A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
US20100081925A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
CN112067382A (en) * 2020-08-07 2020-12-11 佛山科学技术学院 Preparation method of small intestine slices

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162202A (en) * 1989-12-12 1992-11-10 Shamsuddin Abulkalam M Rectal mucus test and kit for detecting cancerous and precancerous conditions
US5416025A (en) * 1993-11-29 1995-05-16 Krepinsky; Jiri J. Screening test for early detection of colorectal cancer
EP1125131A1 (en) * 1998-11-06 2001-08-22 Jiri J. Krepinsky Screening test for early detection of colorectal cancer

Also Published As

Publication number Publication date
US20020022240A1 (en) 2002-02-21
WO2001061358A9 (en) 2002-07-18
CA2299210A1 (en) 2001-08-17
WO2001061358A1 (en) 2001-08-23

Similar Documents

Publication Publication Date Title
AU2002230650A1 (en) Method for diagnosing pathology in biological samples
MXPA03009496A (en) Objective manifest refraction.
AU2002244157A1 (en) Extracting cell shape information contained in cell images
AU2002236666A1 (en) Measuring distances in the eye
AU2002248740A1 (en) Synthetic transaction monitor
AU2001233537A1 (en) A method of assessing the biological status of pathology in epithelial tissue, especially colon
AU5504601A (en) Intraocular pressure measurement
AU2001266587A1 (en) Statistical image analysis
AU2001293035A1 (en) Hydrocracking process
AU2001290623A1 (en) Interbank process
AU2001270478A1 (en) Gene expression in biological conditions
AU2002363338A1 (en) Diagnostics and therapeutics for ocular abnormalities
AU4039701A (en) Measuring microscope
AUPQ749100A0 (en) New epilespy gene
AU2001258827A1 (en) Method for examining WT1-related disease
AU5039200A (en) Reciprocating biological filter
AUPR022000A0 (en) Automated wagering
AU2002325843A1 (en) Method for determining the interaction between keratinocytes and neurons
AU2001287754A1 (en) Impactor
AU2001281712A1 (en) Spectacle side
AU2001274683A1 (en) Contrast agents
AU2001251568A1 (en) Hemolysin fusion proteins, their production and use
GB0320530D0 (en) Female urine dispencer F.U.D
AU2001224482A1 (en) Biological fluid filter
AU2001268672A1 (en) Secreted redox proteins